Zhou X, Zou L, Chen W, Yang T, Luo J, Wu K, et al
Dark yellow or amber-colored urine signals dehydration and increased UTI risk
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
This appointment lets your provider assess your overall health and ask about your previous medical history, which can help them determine if you are a good candidate for oral semaglutide drops
Taking your semaglutide injection in the evening gives your body the nighttime hours to process initial side effects while you sleep